Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. METHODS: In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. RESULTS: The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group (P=0.003), with a significant difference among patients 25 years of age or older that favored the continuous-monitoring group (mean difference in change, -0.53%; 95% confidence interval [CI], -0.71 to -0.35; P<0.001). The between-group difference was not significant among those who were 15 to 24 years of age (mean difference, 0.08; 95% CI, -0.17 to 0.33; P=0.52) or among those who were 8 to 14 years of age (mean difference, -0.13; 95% CI, -0.38 to 0.11; P=0.29). Secondary glycated hemoglobin outcomes were better in the continuous-monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. CONCLUSIONS: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large trial of rt-CGM in people with type 1 diabetes showing significant reductions in HbA 1c in adults (159), improved glucose control was not seen in children (ages 8 to 14 years) or adolescents and young adults (ages 15 to 24 years).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Most randomized controlled trials (RCTs) in adults with type 1 diabetes show that rt-CGM leads to lower HbA 1c (156-159) and reduced time in the hypoglycemic range (160,161).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [159]
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [22]
In the citing paper
“Tamborlane and colleagues91 reported that a real-time continuous glucose monitoring system decreased the amount of time spent in hypoglycaemia (<4 mmol/L [70 mg/dL]) and lowered HbA1C when used by patients an average of 6 days a week.”
From Type 1 diabetes (2014) · cites this paper as [91]
In the citing paper
“In this study, the degree of HbA1C reduction directly correlated with higher HbA1C concentrations before beginning continuous glucose monitoring.”
From Type 1 diabetes (2014) · cites this paper as [91]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Self-citationStandards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEpidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Research works printed but not linked: 1
- Little RJA, Rubin DB. Statistical analysis with missing data. New York: John Wiley, 1987.
Cited by
Items 201–300 of 1,001
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0846 · Cited by 120
Self-citationBeck, R. W., Riddlesworth, T. D., Ruedy, K. J., Kollman, C., Ahmann, A. J., Bergenstal, R. M., Bhargava, A., Bode, B. W., Haller, S., Kruger, D. F., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30217-6 · Cited by 119
Katz, M. L., Volkening, L. K., Butler, D. A., Anderson, B. J., & Laffel, L. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12065 · Cited by 118
Burckhardt, M.-A., Roberts, A., Smith, G. J., Abraham, M. B., Davis, E. A., & Jones, T. W. (2018) · Diabetes Care · doi:10.2337/dc18-0938 · Cited by 116
Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes
Eren-Oruklu, M., Çınar, A., Quinn, L. T., & SMITH, D. P. (2009) · Journal of Process Control · doi:10.1016/j.jprocont.2009.04.004 · Cited by 120
Haidar, A., Legault, L., Matteau‐Pelletier, L., Messier, V., Dallaire, M., Ladouceur, M., & RABASA-LHORET, R. P. R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00141-2 · Cited by 129
Messer, L. H., Johnson, R., Driscoll, K. A., & Jones, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13568 · Cited by 137
Latres, E., Finan, D. A., Greenstein, J. L., Kowalski, A., & Kieffer, T. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.007 · Cited by 117
Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use
Tanenbaum, M. L., Adams, R. N., Hanes, S. J., Barley, R. C., Miller, K. M., Mulvaney, S. A., & Hood, K. K. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816688010 · Cited by 117
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang, E. S., O'Grady, M., Basu, A., Winn, A., John, P., Lee, J., Meltzer, D., Kollman, C., Laffel, L., Tamborlane, W., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 117
Overview on self-monitoring of blood glucose
Montagnana, M., Caputo, M., Giavarina, D., & Lippi, G. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.002 · Cited by 116
Isganaitis, E., Raghinaru, D., Ambler-Osborn, L., Pinsker, J. E., Buckingham, B. A., Wadwa, R. P., Ekhlaspour, L., Kudva, Y. C., Levy, C. J., Forlenza, G. P., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0572 · Cited by 115
Ólafsdóttir, A. F., Polonsky, W., Bolinder, J., Hirsch, I. B., Dahlqvist, S., Wedel, H., Nyström, T., Wijkman, M., Schwarcz, E., Hellman, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0363 · Cited by 113
Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation
Perkins, B. A., Sherr, J. L., & Mathieu, C. (2021) · Science · doi:10.1126/science.abg4502 · Cited by 122
Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R., Dalla Man, C., Kudva, Y. C., Basu, A., & Cobelli, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0192 · Cited by 113
Gingras, V., Taleb, N., Roy‐Fleming, A., Legault, L., & Rabasa‐Lhoret, R. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13052 · Cited by 113
Pathway to Artificial Pancreas Systems Revisited: Moving Downstream
Kowalski, A. (2015) · Diabetes Care · doi:10.2337/dc15-0364 · Cited by 113
AADE Guidelines for the Practice of Diabetes Self-Management Education and Training (DSME/T)
American Association of Diabetes Educators (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709352436 · Cited by 145
Type 1 Diabetes in Children and Adolescents
Wherrett, D. K., Huot, C., Mitchell, B. D., & Pacaud, D. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.042 · Cited by 130
Chua, B., Desai, S. P., Tierney, M. J., Tamada, J. A., & Jina, A. N. (2013) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2013.09.026 · Cited by 111
Use of continuous glucose monitoring in children and adolescents *
Phillip, M., Danne, T., Shalitin, S., Buckingham, B. A., Laffel, L. M., Tamborlane, W. V., Battelino, T., & Participants, F. T. C. F. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00849.x · Cited by 122
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Tauschmann, M., Forlenza, G., Hood, K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13451 · Cited by 100
Ehrhardt, N., & Al Zaghal, E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818790994 · Cited by 105
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2746340 · Cited by 111
Routine Sensor-Augmented Pump Therapy in Type 1 Diabetes: The INTERPRET Study
Nørgaard, K., Scaramuzza, A., Bratina, N., Lalić, N. M., Jarosz-Chobot, P., Kocsis, G., Jasinskiene, E., De Block, C., Carrette, O., Castañeda, J., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0288 · Cited by 107
Dicembrini, I., Cosentino, C., Monami, M., Mannucci, E., & Pala, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01589-3 · Cited by 106
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
Jackson, M. A., Ahmann, A., & Shah, V. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0007 · Cited by 106
Real-Time Improvement of Continuous Glucose Monitoring Accuracy
Facchinetti, A., Sparacino, G., Guerra, S., Luijf, Y. M., DeVries, J. H., Mader, J. K., Ellmerer, M., Benesch, C., Heinemann, L., Bruttomesso, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0736 · Cited by 106
Cameron, F., de Beaufort, C., Aanstoot, H.-J., Hoey, H., Lange, K., Castano, L., Mortensen, H., & the Hvidoere International Study Group (2013) · Pediatric Diabetes · doi:10.1111/pedi.12036 · Cited by 106
Self-citationTaylor, P. J., Thompson, C. H., & Brinkworth, G. D. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12807 · Cited by 105
Zecchin, C., Facchinetti, A., Sparacino, G., & Cobelli, C. (2013) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2013.09.016 · Cited by 114
Elbalshy, M., Haszard, J., Smith, H., Kuroko, S., Galland, B., Oliver, N., Shah, V., de Bock, M. I., & Wheeler, B. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14854 · Cited by 104
Enhancing self-management in type 1 diabetes with wearables and deep learning
Zhu, T., Uduku, C., Li, K., Herrero, P., Oliver, N., & Georgiou, P. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00626-5 · Cited by 97
Hu, X., Gattis, C., Olroyd, A. G., Friera, A. M., White, K., Young, C., Basco, R., Lamba, M., Wells, F., Ankala, R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg5794 · Cited by 99
Buckingham, B. A., Cameron, F., Calhoun, P., Maahs, D. M., Wilson, D. M., Chase, H. P., Bequette, B. W., Lum, J., Sibayan, J., Beck, R. W., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0040 · Cited by 102
Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
Zhang, Z., Miao, L.-F., Qian, L., Wang, N., Qi, M., Zhang, Y., Dang, S., Wu, Y., & Wang, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00640 · Cited by 119
Campbell, F. M., Murphy, N. P., Stewart, C., Biester, T., & Kordonouri, O. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12735 · Cited by 102
“pants in the intervention and control groups in the Juvenile Diabetes Research Foundation (JDRF) trial in CGM did not reach significance.(6)”
BackgroundQuality-of-Life Measures in Children and Adults With Type 1 Diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc10-0331 · Cited by 101
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0015 · Cited by 99
Tumminia, A., Crimi, S., Sciacca, L., Buscema, M., Frittitta, L., Squatrito, S., Vigneri, R., & Tomaselli, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2557 · Cited by 100
Care of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99
Closed-loop insulin delivery for treatment of type 1 diabetes
Elleri, D., Dunger, D. B., & Hovorka, R. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-120 · Cited by 114
Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms
Keenan, D. B., Mastrototaro, J. J., Zisser, H., Cooper, K. A., Raghavendhar, G., Lee, S. W., Yusi, J., Bailey, T. S., Brazg, R. L., & Shah, R. V. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0199 · Cited by 99
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
Kudva, Y. C., Ahmann, A. J., Bergenstal, R. M., Gavin, J. R., Kruger, D. F., Midyett, L. K., Miller, E., & Harris, D. R. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00294 · Cited by 97
Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches
Bent, B., Cho, P. J., Henriquez, M., Wittmann, A., Thacker, C., Feinglos, M., Crowley, M. J., & Dunn, J. P. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00465-w · Cited by 94
Blevins, T. C., Bode, B. W., Garg, S. K., Grunberger, G., Hirsch, I. B., Jovanovič, L., Nardacci, E., Orzeck, E. A., Roberts, V. L., & Tamborlane, W. V. (2010) · Endocrine Practice · doi:10.4158/ep.16.5.730 · Cited by 98
Berard, L., Blumer, I. R., Houlden, R. L., Miller, D. B., & Woo, V. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.017 · Cited by 106
Susceptibility of Interstitial Continuous Glucose Monitor Performance to Sleeping Position
Mensh, B. D., Wisniewski, N. A., Neil, B. M., & Burnett, D. R. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700408 · Cited by 97
Continuous glucose monitoring: Current use in diabetes management and possible future applications
Vettoretti, M., Cappon, G., Acciaroli, G., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818774078 · Cited by 96
Zahedani, A. D., McLaughlin, T., Veluvali, A., Aghaeepour, N., Hosseinian, A., Agarwal, S., Ruan, J., Tripathi, S., Woodward, M., Hashemi, N., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00956-y · Cited by 96
Riveline, J.-P., Schaepelynck, P., Chaillous, L., Renard, E., Sola-Gazagnes, A., Penfornis, A., Tubiana-Rufi, N., Sulmont, V., Catargi, B., Lukas, C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2021 · Cited by 94
Adherence to Glycemic Monitoring in Diabetes
Patton, S. R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814567709 · Cited by 95
Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy
Castle, J. R., & Ward, W. K. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400127 · Cited by 95
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
Kovatchev, B., Tamborlane, W. V., Cefalu, W. T., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc16-0824 · Cited by 95
“Smart” Continuous Glucose Monitoring Sensors: On-Line Signal Processing Issues
Sparacino, G., Facchinetti, A., & Cobelli, C. (2010) · Sensors · doi:10.3390/s100706751 · Cited by 96
Delbeck, S., Vahlsing, T., Leonhardt, S. K., Steiner, G. R., & Heise, H. M. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1395-x · Cited by 108
Akinetic mutism: disconnection of frontal-subcortical circuits.
Mega, M. S., & COHENOUR, R. C. (1997) · PubMed · Cited by 108
Sharifi, A., De Bock, M. I., Jayawardene, D., Loh, M. M., Horsburgh, J. C., Berthold, C. L., Paramalingam, N., Bach, L. A., Colman, P. G., Davis, E. A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0288 · Cited by 91
Miller, K. M., Hermann, J., Foster, N., Hofer, S. E., Rickels, M. R., Danne, T., Clements, M. A., Lilienthal, E., Maahs, D. M., Holl, R. W., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1214 · Cited by 92
Benefits and Challenges of Diabetes Technology Use in Older Adults
Toschi, E., & Munshi, M. N. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.001 · Cited by 91
Garg, S. K., Smith, J., Beatson, C., Lopez-Baca, B., Voelmle, M., & Gottlieb, P. A. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0109 · Cited by 93
Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist
Hirsch, I. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2625 · Cited by 93
Reddy, M., Jugnee, N., Anantharaja, S., & Oliver, N. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0252 · Cited by 91
Dermal Tattoo Biosensors for Colorimetric Metabolite Detection
Yetisen, A. K., Moreddu, R., Seifi, S., Jiang, N., Vega, K. C., Dong, X., Dong, J., Butt, H., Jakobi, M., Elsner, M., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904416 · Cited by 100
Micro additive manufacturing of glucose biosensors: A feasibility study
Nesaei, S., Song, Y., Wang, Y., Ruan, X., Du, D., Gozen, B. A., & Lin, Y. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.09.012 · Cited by 93
Monnier, L., Colette, C., & Owens, D. R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.962 · Cited by 89
Continuous glucose monitoring in type 1 diabetes
Mauras, N., Fox, L. A., ENGLERT, K. A., & Beck, R. W. (2012) · Endocrine · doi:10.1007/s12020-012-9765-1 · Cited by 98
Type 1 Diabetes in Children and Adolescents
Wherrett, D. K., Ho, J., Huot, C., Legault, L., Nakhla, M. M., & Rosolowsky, E. T. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.036 · Cited by 114
Psychosocial factors associated with use of continuous glucose monitoring
Ritholz, M. D., Atakov‐Castillo, A., Beste, M., Beverly, E. A., Leighton, A., Weinger, K., & Wolpert, H. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03061.x · Cited by 88
Lee, S.-K., Shin, D.-H., Kim, Y.-H., & Lee, K.-S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16183323 · Cited by 87
Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes
Slattery, D., & Choudhary, P. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0051 · Cited by 87
Runge, A. S., Kennedy, L., Brown, A. S., Dove, A. E., Levine, B. J., Koontz, S. P., Iyengar, V. S., Odeh, S. A., Close, K. L., Hirsch, I. B., et al. (2018) · Clinical Diabetes · doi:10.2337/cd17-0094 · Cited by 87
Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review
Hoeks, L. B. E. A., Greven, W. L., & de Valk, H. W. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03177.x · Cited by 88
Little, S. A., Speight, J., Leelarathna, L., Walkinshaw, E., Tan, H. K., Bowes, A., Lubina-Solomon, A., Chadwick, T. J., Stocken, D. D., Brennand, C., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2682 · Cited by 86
Johnson, S. R., Holmes-Walker, D. J., Chee, M., Earnest, A., & Jones, T. W. (2022) · Diabetes Care · doi:10.2337/dc21-1666 · Cited by 86
Laffel, L. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0380 · Cited by 70
Garg, S. K., Voelmle, M. K., Beatson, C. R., Miller, H. A., Crew, L. B., Freson, B. J., & Hazenfield, R. M. (2011) · Diabetes Care · doi:10.2337/dc10-1852 · Cited by 85
Evolution of Diabetes Technology
Dovč, K., & Battelino, T. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.009 · Cited by 132
Engler, R., Routh, T. L., & Lucisano, J. Y. (2018) · Clinical Diabetes · doi:10.2337/cd17-0053 · Cited by 84
Patek, S. D., Bequette, B. W., Breton, M., Buckingham, B. A., Dassau, E., Doyle, F. J., Lum, J., Magni, L., & Zisser, H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300207 · Cited by 83
DiAs User Interface: A Patient-Centric Interface for Mobile Artificial Pancreas Systems
Keith-Hynes, P., Guerlain, S., Mize, B., Hughes-Karvetski, C., Khan, M., McElwee-Malloy, M., & Kovatchev, B. P. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700602 · Cited by 85
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network (DirecNet) Study Group (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00837.x · Cited by 83
Automated sensing of daily activity: A new lens into development
de Barbaro, K. (2019) · Developmental Psychobiology · doi:10.1002/dev.21831 · Cited by 85
REDONDO, M. J., Libman, I. M., Maahs, D. M., Lyons, S. K., Saraco, M., Reusch, J. E. B., Rodriguez, H., & DiMeglio, L. A. (2021) · Diabetes Care · doi:10.2337/dc20-1978 · Cited by 95
The AJT Report: News and issues that affect organ and tissue transplantation
Pondrom, S. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04186.x · Cited by 87
El-Laboudi, A. H., Godsland, I. F., Johnston, D. G., & Oliver, N. S. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0146 · Cited by 84
Aleppo, G., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1304 · Cited by 82
Lin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
A review on B-type natriuretic peptide monitoring: assays and biosensors
Maalouf, R., & Bailey, S. R. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9544-9 · Cited by 90
Pease, A., Lo, C., Earnest, A., Kiriakova, V., Liew, D., & Zoungas, S. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0417 · Cited by 83
Azeez, S., Jafar, S., Aziziaram, Z., Fang, L., Mawlood, A. H., & Ercisli, M. F. (2021) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2021.138888.1006 · Cited by 82
Renard, É. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0189 · Cited by 89
Shrivastav, M., Gibson, W., Shrivastav, R., Elzea, K., Khambatta, C., Sonawane, R., Sierra, J. A., & Vigersky, R. A. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0024 · Cited by 96
The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes
Fonda, S. J., Graham, C., Munakata, J., Powers, J. M., Price, D., & Vigersky, R. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816628547 · Cited by 81
New, J. P., Ajjan, R., Pfeiffer, A. F. H., & Freckmann, G. (2015) · Diabetic Medicine · doi:10.1111/dme.12713 · Cited by 80
Rubin, R. R., & Peyrot, M. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0162 · Cited by 82
Automated closed-loop control of diabetes: the artificial pancreas
Kovatchev, B. (2018) · Bioelectronic Medicine · doi:10.1186/s42234-018-0015-6 · Cited by 80
“As a result, a number of studies have documented the benefits of CGM technology (Deiss et al. 2006; Garg et al. 2006; Kovatchev and Clarke 2007; The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group 2008) and envisioned its use in closed-loop control systems (Klonoff 2005; Hovorka 2006; K…”
BackgroundInfluentialAsarani, N. A. M., Reynolds, A. N., Boucher, S. E., de Bock, M., & Wheeler, B. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 81
Facchinetti, A., Del Favero, S., Sparacino, G., & Cobelli, C. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-014-1226-y · Cited by 80
Skin and Adhesive Issues With Continuous Glucose Monitors: A Sticky Situation
Englert, K., Ruedy, K., Coffey, J., Caswell, K., Steffen, A., Levandoski, L., for the Diabetes Research in Children (DirecNet) Study Group, Tsalikian, E., Tansey, M. J., Coffey, J., et al. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814529893 · Cited by 77
Metadata
- Authors
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Affiliations
- Yale University (US)
- Corresponding author
- The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-02
- Volume
- 359
- Issue
- 14
- Pages
- 1464-1476
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1531505795
- Semantic Scholar
- b1462f3524589cf66909ea165b57d41352a0293b
- Cited by
- 1,559
- References
- 30
- Citations by year
- 2026: 29 · 2025: 60 · 2024: 64 · 2023: 54 · 2022: 61 · 2021: 103 · 2020: 104 · 2019: 90 · 2018: 109 · 2017: 101 · 2016: 95 · 2015: 85 · 2014: 79 · 2013: 86 · 2012: 104
- FWCI
- 79.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, intensive insulin therapy, HbA1c, glycemic control, age differences, children and adolescents, severe hypoglycemia
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Subcutaneous, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Monitoring, Ambulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.